Literature DB >> 1822098

Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review.

A Erice1, F S Rhame, R C Heussner, D L Dunn, H H Balfour.   

Abstract

Five recipients of solid-organ transplants who were infected with human immunodeficiency virus (HIV) were studied at the University of Minnesota, and our data were compared with data from 83 reported cases of HIV-infected recipients of solid organs from other centers. Sixty-six of the 88 patients were seronegative for HIV before transplantation and received organs or transfusions of blood from individuals who were seropositive for HIV. Seven patients (four recipients of kidney transplants and three recipients of liver transplants) received transplants after routine screening for HIV. Twenty-five (28%) of the 88 patients developed AIDS, and 20 (80%) of these 25 patients died of AIDS-related complications a mean of 37 months after transplantation. Another nine patients (10%) had other HIV-related diseases. The mean time of progression to AIDS was 27.5 months among all patients with AIDS. For patients who were seronegative for HIV at the time of transplantation, the mean time of progression to AIDS was 32 months, whereas patients seropositive before transplantation developed AIDS within 17 months. Shortly after transplantation, eleven (17%) of the patients who were initially seronegative experienced a febrile syndrome attributed to HIV. Ten patients, including eight recipients of kidney transplants and two recipients of liver transplants, maintained normal allograft function despite low-dose immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1822098     DOI: 10.1093/clinids/13.4.537

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  18 in total

Review 1.  Solid organ transplantation is a reality for patients with HIV infection.

Authors:  Michelle E Roland; Peter G Stock
Journal:  Curr HIV/AIDS Rep       Date:  2006-09       Impact factor: 5.071

2.  Solid organ transplantation and HIV: A changing paradigm.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-11       Impact factor: 2.471

Review 3.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 4.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

5.  Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience.

Authors:  Henkie P Tan; David J Kaczorowski; Amit Basu; Akhtar Khan; Jerry McCauley; Amadeo Marcos; John J Fung; Thomas E Starzl; Ron Shapiro
Journal:  Transplantation       Date:  2004-12-15       Impact factor: 4.939

6.  [Organ transplantation in human immunodeficiency virus-infected patients. Results of a survey in German transplantation centres].

Authors:  N R Frühauf; R Köditz; K Radecke; M Malagó; H Lang; C E Broelsch
Journal:  Chirurg       Date:  2004-07       Impact factor: 0.955

7.  Organ Transplantation and HIV Progress or Success? A Review of Current Status.

Authors:  Alan Taege
Journal:  Curr Infect Dis Rep       Date:  2013-02       Impact factor: 3.725

Review 8.  Perspectives on liver and kidney transplantation in the human immunodeficiency virus-infected patient.

Authors:  Peter Chin-Hong; George Beatty; Peter Stock
Journal:  Infect Dis Clin North Am       Date:  2013-03-29       Impact factor: 5.982

9.  Donor-derived infection: epidemiology and outcomes.

Authors:  Daniel R Kaul
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725

Review 10.  Solid organ transplants in HIV-infected patients.

Authors:  Jack Harbell; Norah A Terrault; Peter Stock
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.